460
Views
7
CrossRef citations to date
0
Altmetric
Review

The unknown burden and cost of celiac disease in the U.S

, , , &
Pages 181-188 | Received 17 Aug 2016, Accepted 30 Mar 2017, Published online: 12 Apr 2017

References

  • Kelly CP, Bai JC, Liu E, et al. Advances in diagnosis and management of celiac disease. Gastroenterology. 2015 May;148(6):1175–1186.
  • Ludvigsson JF, Rubio-Tapia A, Van Dyke CT, et al. Increasing incidence of celiac disease in a North American population. Am J Gastroenterol. 2013 May;108(5):818–824.
  • Lohi S, Mustalahti K, Kaukinen K, et al. Increasing prevalence of coeliac disease over time. Aliment Pharmacol Ther. 2007 Nov 1;26(9):1217–1225.
  • Rubio-Tapia A, Ludvigsson JF, Brantner TL, et al. The prevalence of celiac disease in the United States. Am J Gastroenterol. 2012 Oct;107(10):1538–1545.
  • Rubio-Tapia A, Kyle RA, Kaplan EL, et al. Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology. 2009 Jul;137(1):88–93.
  • Lopez AD. The evolution of the Global Burden of Disease framework for disease, injury and risk factor quantification: developing the evidence base for national, regional and global public health action. Glob Health. 2005 Apr 22;1(1):5.
  • Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease study. Lancet Lond Engl. 1997 May 17;349(9063):1436–1442.
  • Murray CJL, Lopez AD. Measuring the global burden of disease. N Engl J Med. 2013 Aug 1;369(5):448–457.
  • Larg A, Moss JR. Cost-of-illness studies: a guide to critical evaluation. PharmacoEconomics. 2011 Aug;29(8):653–671.
  • Hodgson TA, Meiners MR. Cost-of-illness methodology: a guide to current practices and procedures. Milbank Mem Fund Q Health Soc. 1982;60(3):429–462.
  • Luppa M, Heinrich S, Angermeyer MC, et al. Cost-of-illness studies of depression: a systematic review. J Affect Disord. 2007 Feb;98(1–2):29–43.
  • Rice DP, Hodgson TA, Kopstein AN. The economic costs of illness: a replication and update. Health Care Financ Rev. 1985;7(1):61–80.
  • Violato M, Gray A, Papanicolas I, et al. Resource use and costs associated with coeliac disease before and after diagnosis in 3,646 cases: results of a UK primary care database analysis. Plos One. 2012;7(7):e41308.
  • Rubio-Tapia A, Hill ID, Kelly CP, et al. American College of gastroenterology. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol. 2013 May;108(5):656–676;quiz 677.
  • Katz KD, Rashtak S, Lahr BD, et al. Screening for celiac disease in a North American population: sequential serology and gastrointestinal symptoms. Am J Gastroenterol. 2011 Jul;106(7):1333–1339.
  • Hill ID, Dirks MH, Liptak GS, et al. Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2005 Jan;40(1):1–19.
  • Norström F, Lindholm L, Sandström O, et al. Delay to celiac disease diagnosis and its implications for health-related quality of life. BMC Gastroenterol. 2011 Nov;7(11):118.
  • Fuchs V, Kurppa K, Huhtala H, et al. Factors associated with long diagnostic delay in celiac disease. Scand J Gastroenterol. 2014 Nov;49(11):1304–1310.
  • Gray AM, Papanicolas IN. Impact of symptoms on quality of life before and after diagnosis of coeliac disease: results from a UK population survey. BMC Health Serv Res. 2010;10:105.
  • Mahadev S, Gardner R, Lewis SK, et al. Quality of life in screen-detected celiac disease patients in the United States. J Clin Gastroenterol. 2016 Jun;50(5):393–397.
  • Oza SS, Akbari M, Kelly CP, et al. Socioeconomic risk factors for celiac disease burden and symptoms. J Clin Gastroenterol. 2015 Jun 4;50(4):307–312.
  • Altobelli E, Paduano R, Gentile T, et al. Health-related quality of life in children and adolescents with celiac disease: survey of a population from central Italy. Health Qual Life Outcomes. 2013;11:204.
  • Nordyke K, Norström F, Lindholm L, et al. Health-related quality of life in adolescents with screening-detected celiac disease, before and one year after diagnosis and initiation of gluten-free diet, a prospective nested case-referent study. BMC Public Health. 2013 Feb;13(1):142.
  • Nordyke K, Norström F, Lindholm L, et al. Health-related quality-of-life in children with coeliac disease, measured prior to receiving their diagnosis through screening. J Med Screen. 2011;18(4):187–192.
  • Casellas F, Rodrigo L, Vivancos JL, et al. Factors that impact health-related quality of life in adults with celiac disease: a multicenter study. World J Gastroenterol. 2008 Jan 7;14(1):46–52.
  • Häuser W, Stallmach A, Caspary WF, et al. Predictors of reduced health-related quality of life in adults with coeliac disease. Aliment Pharmacol Ther. 2007 Mar 1;25(5):569–578.
  • Zarkadas M, Cranney A, Case S, et al. The impact of a gluten-free diet on adults with coeliac disease: results of a national survey. J Hum Nutr Diet Off J Br Diet Assoc. 2006 Feb;19(1):41–49.
  • Johnston SD, Rodgers C, Watson RG. Quality of life in screen-detected and typical coeliac disease and the effect of excluding dietary gluten. Eur J Gastroenterol Hepatol. 2004 Nov;16(12):1281–1286.
  • Oza SS, Akbari M, Kelly CP, et al. Socioeconomic risk factors for celiac disease burden and symptoms. J Clin Gastroenterol. 2016 Apr;50(4):307–312.
  • Mattila E, Kurppa K, Ukkola A, et al. Burden of illness and use of health care services before and after celiac disease diagnosis in children. J Pediatr Gastroenterol Nutr. 2013 Jul;57(1):53–56.
  • Lee AR, Ng DL, Diamond B, et al. Living with coeliac disease: survey results from the U.S.A. J Hum Nutr Diet Off J Br Diet Assoc. 2012 Jun;25(3):233–238.
  • Shah S, Akbari M, Vanga R, et al. Patient perception of treatment burden is high in celiac disease compared with other common conditions. Am J Gastroenterol. 2014 Sep;109(9):1304–1311.
  • Hall NJ, Rubin G, Charnock A. Systematic review: adherence to a gluten-free diet in adult patients with coeliac disease. Aliment Pharmacol Ther. 2009 Aug 15;30(4):315–330.
  • Barratt SM, Leeds JS, Sanders DS. Quality of life in Coeliac Disease is determined by perceived degree of difficulty adhering to a gluten-free diet, not the level of dietary adherence ultimately achieved. J Gastrointest Liver Dis JGLD. 2011 Sep;20(3):241–245.
  • Aziz I, Evans KE, Papageorgiou V, et al. Are patients with coeliac disease seeking alternative therapies to a gluten-free diet? J Gastrointest Liver Dis JGLD. 2011 Mar;20(1):27–31.
  • Solaymani-Dodaran M, West J, Logan RFA. Long-term mortality in people with celiac disease diagnosed in childhood compared with adulthood: a population-based cohort study. Am J Gastroenterol. 2007 Apr;102(4):864–870.
  • Ludvigsson JF, Montgomery SM, Ekbom A, et al. Small-intestinal histopathology and mortality risk in celiac disease. Jama. 2009 Sep 16;302(11):1171–1178.
  • Abdul Sultan A, Crooks CJ, Card T, et al. Causes of death in people with coeliac disease in England compared with the general population: a competing risk analysis. Gut. 2014 Oct;24.
  • Peters U, Askling J, Gridley G, et al. Causes of death in patients with celiac disease in a population-based Swedish cohort. Arch Intern Med. 2003 Jul 14;163(13):1566–1572.
  • Corrao G, Corazza GR, Bagnardi V, et al. Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet Lond Engl. 2001 Aug 4;358(9279):356–361.
  • Altobelli E, Paduano R, Petrocelli R, et al. Burden of celiac disease in Europe: a review of its childhood and adulthood prevalence and incidence as of September 2014. Ann Ig Med Prev E Comunità. 2014 Dec;26(6):485–498.
  • Choung RS, Ditah IC, Nadeau AM, et al. Trends and racial/ethnic disparities in gluten-sensitive problems in the United States: findings from the National Health and Nutrition Examination Surveys from 1988 to 2012. Am J Gastroenterol. 2015 Mar;110(3):455–461.
  • Krigel A, Turner KO, Makharia GK, et al. Ethnic variations in duodenal villous atrophy consistent with celiac disease in the United States. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2016 Aug;14(8):1105–1111.
  • Murray JA, Van Dyke C, Plevak MF, et al. Trends in the identification and clinical features of celiac disease in a North American community, 1950-2001. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2003 Jan;1(1):19–27.
  • Tanpowpong P, Broder-Fingert S, Obuch JC, et al. Multicenter study on the value of ICD-9-CM codes for case identification of celiac disease. Ann Epidemiol. 2013 Mar;23(3):136–142.
  • Luthra P, Ford AC. Screening for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: still a worthwhile exercise. Gastroenterology. 2016 Aug;151(2):368–370.
  • Vazquez-Roque M, Oxentenko AS. Nonceliac gluten sensitivity. Mayo Clin Proc. 2015 Sep;90(9):1272–1277.
  • Sánchez-Vargas LA, Thomas-Dupont P, Torres-Aguilera M, et al. Prevalence of celiac disease and related antibodies in patients diagnosed with irritable bowel syndrome according to the Rome III criteria. J Eur Gastrointest Motil Soc. 2016 Jul;28(7):994–1000.
  • Riddle MS, Murray JA, Porter CK. The incidence and risk of celiac disease in a healthy US adult population. Am J Gastroenterol. 2012 Aug;107(8):1248–1255.
  • Long KH, Rubio-Tapia A, Wagie AE, et al. The economics of coeliac disease: a population-based study. Aliment Pharmacol Ther. 2010 Jul;32(2):261–269.
  • Green PHR, Neugut AI, Naiyer AJ, et al. Economic benefits of increased diagnosis of celiac disease in a national managed care population in the United States. J Insur Med N Y N. 2008;40(3–4):218–228.
  • Pinto-Sanchez MI, Verdu EF, Gordillo MC, et al. Tax-deductible provisions for gluten-free diet in Canada compared with systems for gluten-free diet coverage available in various countries. Can J Gastroenterol Hepatol. 2015 Mar;29(2):104–110.
  • Lee AR, Ng DL, Zivin J, et al. Economic burden of a gluten-free diet. J Hum Nutr Diet Off J Br Diet Assoc. 2007 Oct;20(5):423–430.
  • Hershcovici T, Leshno M, Goldin E, et al. Cost effectiveness of mass screening for coeliac disease is determined by time-delay to diagnosis and quality of life on a gluten-free diet. Aliment Pharmacol Ther. 2010 Apr;31(8):901–910.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.